ArticlePoultry science2026
Green tea extract disrupts gonadal differentiation in a model avian system.
Article in Poultry science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In the poultry industry, green tea extract (GTE) is becoming an increasingly popular dietary supplement due to its observed beneficial effects on performance and egg quality. However, work in mammals indicates that the active ingredients in green tea extract, catechins, act as endocrine disruptors, interfering with the actions of estrogen. Given that GTE is often supplemented to hens during egg-laying, there is potential for the endocrine-disrupting properties of catechins to interfere with the sensitive process of sexual differentiation in embryos. We tested whether green tea extract (GTE) alters gonadal differentiation in Japanese quail (Coturnix japonica) embryos. We injected eggs with either GTE or a Control vehicle before the onset of differentiation on the 4th day of incubation. On day 15, we evaluated phenotypic sex (gonadal morphology) and genetic sex (via PCR). Embryos from eggs that were injected with GTE had increased genotype-phenotype mismatches, which occurred exclusively in genetic females (ZW) who developed bilateral gonads resembling testes. Among genetic females, GTE significantly increased the probability of a male phenotype. Treatment with GTE did not increase embryonic mortality compared to Controls. We conclude that GTE modifies the developmental trajectory of embryonic gonads, specifically for female embryos. We propose that GTE disrupts the critical estrogen-dependent window of female sex differentiation, leading to sex reversal.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.